191 related articles for article (PubMed ID: 17979810)
1. Cyclin-dependent kinase 5 (Cdk5): a potential therapeutic target for the treatment of neurodegenerative diseases and diabetes mellitus.
Wei FY; Tomizawa K
Mini Rev Med Chem; 2007 Oct; 7(10):1070-4. PubMed ID: 17979810
[TBL] [Abstract][Full Text] [Related]
2. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
[TBL] [Abstract][Full Text] [Related]
3. [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].
Chen J; Wang ZF
Sheng Li Xue Bao; 2010 Aug; 62(4):295-308. PubMed ID: 20717630
[TBL] [Abstract][Full Text] [Related]
4. Physiological and Pathological Roles of Cdk5: Potential Directions for Therapeutic Targeting in Neurodegenerative Disease.
Allnutt AB; Waters AK; Kesari S; Yenugonda VM
ACS Chem Neurosci; 2020 May; 11(9):1218-1230. PubMed ID: 32286796
[TBL] [Abstract][Full Text] [Related]
5. A review on cyclin-dependent kinase 5: An emerging drug target for neurodegenerative diseases.
Batra S; Jahan S; Ashraf A; Alharby B; Jawaid T; Islam A; Hassan I
Int J Biol Macromol; 2023 Mar; 230():123259. PubMed ID: 36641018
[TBL] [Abstract][Full Text] [Related]
6. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
Hisanaga S; Saito T
Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
[TBL] [Abstract][Full Text] [Related]
7. The role of CDK5/P25 formation/inhibition in neurodegeneration.
Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of p35 in Min6 pancreatic beta cells induces a stressed neuron-like apoptosis.
Zheng YL; Hu YF; Zhang A; Wang W; Li B; Amin N; Grant P; Pant HC
J Neurol Sci; 2010 Dec; 299(1-2):101-7. PubMed ID: 20926102
[TBL] [Abstract][Full Text] [Related]
9. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase-5 in neurodegeneration.
Shelton SB; Johnson GV
J Neurochem; 2004 Mar; 88(6):1313-26. PubMed ID: 15009631
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinases in brain development and disease.
Su SC; Tsai LH
Annu Rev Cell Dev Biol; 2011; 27():465-91. PubMed ID: 21740229
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity.
Ubeda M; Rukstalis JM; Habener JF
J Biol Chem; 2006 Sep; 281(39):28858-64. PubMed ID: 16887799
[TBL] [Abstract][Full Text] [Related]
14. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
Maccioni RB; Otth C; Concha II; Muñoz JP
Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase 5--a neuronal killer?
Guo Q
Sci Aging Knowledge Environ; 2003 Dec; 2003(50):pe36. PubMed ID: 14681576
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclin-dependent kinase 5 activity alleviates diabetes-related cognitive deficits.
Liu W; Zhou Y; Liang R; Zhang Y
FASEB J; 2019 Dec; 33(12):14506-14515. PubMed ID: 31689375
[TBL] [Abstract][Full Text] [Related]
17. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
18. An unusual member of the Cdk family: Cdk5.
Dhariwala FA; Rajadhyaksha MS
Cell Mol Neurobiol; 2008 May; 28(3):351-69. PubMed ID: 18183483
[TBL] [Abstract][Full Text] [Related]
19. Interaction of Cdk5 and cAMP/PKA Signaling in the Mediation of Neuropsychiatric and Neurodegenerative Diseases.
Hu Y; Pan S; Zhang HT
Adv Neurobiol; 2017; 17():45-61. PubMed ID: 28956329
[TBL] [Abstract][Full Text] [Related]
20. Cdk5 activity in the brain - multiple paths of regulation.
Shah K; Lahiri DK
J Cell Sci; 2014 Jun; 127(Pt 11):2391-400. PubMed ID: 24879856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
